The EMA has backed broader pediatric use of Agamree and Crysvita, lowering age thresholds for rare genetic diseases affecting muscle and bone development.
In collaboration with Johns Hopkins Medicine, Kennedy Krieger has started a program treating children with neurofibromatosis, a rare genetic tumor condition.
1. Bone cell biology: osteoclasts, osteoblasts, osteocytes / Katharine Jähn and Lynda F. Bonewald -- 2. Bone matrix and mineralization / Marc D. McKee and William G. Cole -- 3. Prenatal bone ...
Philadelphia, November 19, 2025 – Researchers at Children’s Hospital of Philadelphia (CHOP) revealed important genetic components that affect bone density in children and adolescents. This information ...
For most families, the journey toward a bone marrow transplant does not begin with a clear plan. It begins with uncertainty — a diagnosis that raises more questions than answers, repeated hospital ...
Dr. Cho is currently an assistant professor at the University of Utah School of Medicine in the division of Pediatric Hematology/Oncology. He is a member of the Pediatric Bone Marrow Transplant and ...
AUSTIN (KXAN) — There is a new treatment method for pediatric cancer in Austin. Dell Children’s Hospital completed the first bone marrow transplant — or stem cell transplant — in Central Texas. Local ...
Please provide your email address to receive an email when new articles are posted on . Older patient age was associated with a pronosupination deficit after treatment of both bone forearm fractures.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results